# Endoshape

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/endoshape

- Industry: Medical Devices & Equipment
- Headquarters: Boulder, US
- Website: www.endoshape.com
- Total disclosed funding: $13M
- Latest round: Series D (Aug 4, 2014)
- Investors on record: 2

## About

Endoshape develops innovative minimally invasive medical devices tailored for interventional radiology, focusing on vascular applications. Their advanced technologies aim to improve patient outcomes by enhancing procedural safety and effectiveness.Endoshape, founded in 2006 and headquartered in Boulder, US, specializes in creating medical devices for interventional radiology. The company has completed five deals, with the latest funding round being Venture Debt of USD 3.00 mn raised on January 26, 2016, totaling USD 7.30 mn. The CEO, Jim Kasic, leads the company, though no specific information about any previous companies founded by him was provided.Endoshape's product line focuses on the development of minimally invasive medical devices using advanced radiopaque shape-memory biocompatible polymers. These products are primarily aimed at the interventional radiology market, targeting critical medical challenges in peripheral vascular and neurovascular procedures. The company's devices cater to hospitals and specialized clinics in North America and Europe, emphasizing improved patient outcomes through less invasive options.Endoshape does not market any medical devices in the United States, limiting the ability to outline concrete revenue figures. Typically, revenue generation in the medical device sector occurs through direct sales to healthcare providers facilitated by partnerships and distribution agreements. The company's approach aligns with a B2B model, where hospitals and clinics procure medical devices directly, utilizing standard pricing strategies such as volume-based or tiered pricing models.Endoshape is exploring the development of new products aimed at enhancing their existing offerings, with detailed release information yet to be announced. The company plans to expand its market presence, specifically targeting new regions in North America and Europe by 2017. Recent funding from the USD 3.00 mn venture debt round will support these strategic initiatives, enabling further innovation and market penetration.

## Funding rounds

- Series D, Aug 4, 2014, $7.3M — High Country Venture, Volcano Capital
- Series D, Jun 10, 2014, $5.8M — High Country Venture

## Investors

- High Country Venture (https://capitalatlas.ai/funds/high-country-venture) — Series D
- Volcano Capital (https://capitalatlas.ai/funds/volcano-capital) — Series D